在NSTEMI后hsCRP与高风险脆弱斑块的关系:来自PROSPECT II试验的见解

Ole Fröbert1, Gregg W Stone2, Alf Inge Larsen3

  • 1Faculty of Health, Department of Cardiology, Örebro University, Örebro, Sweden; Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.

概括

高灵敏度C反应蛋白 (hsCRP) 水平与非ST段升高心肌梗塞 (NSTEMI) 患者的高风险冠状动脉斑有关. 升高的hsCRP表明动脉样硬化更严重,危险斑块的存在更大.